Key facts
- Alleviate Health’s last known valuation is $22.0M (May 2025).
- It has raised $4.3M; the latest was Seed Round ($4.3M) in May 2025.
- Notable investors include Andreessen Horowitz, Alt Capital (San Francisco), Duke Innovation and Entrepreneurship, First Harmonic Group (San Francisco).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Alleviate Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Alleviate Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alleviate Health
Developer of an AI-powered recruitment platform designed to significantly reduce recruitment times and costs. The company's platform provides chatbots that screen potential patients based on pre-defined criteria and schedule qualified patients for conversations with human recruiters, eliminating the need for cold-calling, enabling clients to significantly accelerate clinical trial recruitment timelines.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2023
- Employees
- 9
- Website
- alleviatehealth.care/
- Ownership
- Privately Held (backing)
Alleviate Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alleviate Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alleviate Health in its N-PORT filings yet. We sweep new filings monthly.